Invasive Pulmonary Aspergillosis clinical trials at UC Health
1 research study open to new patients
-
VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults
open to eligible people ages 18 years and up
The purpose of the trial is to evaluate the safety and efficacy of a new antifungal with a novel mechanism of action in immunocompromised adults with invasive aspergillosis.
at UC Davis
Last updated: